skip to main content
Language:
Show Results with:
Refined by: collection: MEDLINE/PubMed (NLM) remove collection: Scopus (Elsevier) remove journal title: Lancet remove subject: Therapy remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial
Material Type:
Article 		Add to My workspace

First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial

The Lancet, 20 May 2017, Vol.389(10083), pp.2031-2040 [Peer Reviewed Journal]

No full-text

View all versions

All text is © British Library Board and is available under a Creative Commons Attribution Licence, except where otherwise stated.

P2

Searching Remote Databases, Please Wait